Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

155.18
Delayed Data
As of Jun 28
 +0.32 / +0.21%
Today’s Change
95.80
Today|||52-Week Range
163.75
+42.33%
Year-to-Date

Today’s Trading

Previous close154.86
Today’s open154.71
Day’s range154.36 - 157.45
Volume355,755
Average volume (3 months)526,929
Market cap$9.3B
Dividend yield--
Data as of 06/28/2017

Growth & Valuation

Earnings growth (last year)+22.56%
Earnings growth (this year)+8.47%
Earnings growth (next 5 years)+15.10%
Revenue growth (last year)+12.32%
P/E ratio23.5
Price/Sales4.53
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+1.04+1.82%
SGENSeattle Genetics Inc+3.33+6.48%
TSROTESARO Inc+3.19+2.26%
PRGOPerrigo Company PLC+1.80+2.41%
Data as of 8:47am ET, 06/29/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$2.75
Annual revenue (last year)$1.5B
Annual profit (last year)$396.8M
Net profit margin26.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts